Talk:Abzyme

Assessment comment

The comment(s) below were originally left at Talk:Abzyme/CommentsTalk:Abzyme/Comments, and are posted here for posterity. Following several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section.

Comment(s)

Press [show] to view →

Is there a particular name for that abzyme that they engineered? Supposedly, they have to designate a name for it just like in plasmids e.g. pBR322. Pls. include it in the article so we can refer to it specifically. Thanks a lot. —Preceding unsigned comment added by 203.87.202.142 (talk) 03:43, 19 November 2008 (UTC) Just a few minor comments. The first author of the paper referred to in this article is Stephanie Planque, and she is not mentioned (although Sudhir Paul, Ph.D,and Yasuhiro Nishiyama, Ph.D are). Also, my reading of the article mentioned (but not referenced) in Autoimmunity Reviews, the abzyme in question was not engineered, but isolated from lupus patients. In fact, the article mentions tat the isolated abzymes reduce gp120 more effectively than monclonal antibodies. 12:16, 8 August 2008 (UTC)12:16, 8 August 2008 (UTC) It would be helpful to have some pronunciation guidance. Is it ab-zeem or ab-zym? —Preceding unsigned comment added by 152.75.174.47 (talk) 12:16, 8 August 2008 (UTC)

Last edited at 03:44, 19 November 2008 (UTC). Substituted at 06:33, 29 April 2016 (UTC)

Suggest removing "Potential HIV treatment" section

This section tells the reader nothing about abzymes generally, and may raise false hopes for a new HIV treatment. Also the section was added by an anonymous editor who may be one of the researchers using Wikipedia to publicize his own work. And, one of the references in the section is to a primary source. HandsomeMrToad (talk) 03:02, 4 July 2016 (UTC)